Oracle Corporation (NYSE:ORCL) in last trading activity moved down -2.48% to close at $43.62. Company weekly performance is 0.53% while its quarterly performance stands at 2.13%. Oracle Corporation (NYSE:ORCL) is -6.03% away from its 52 week high. Oracle Corporation (NYSE:ORCL) set the stage on 28 April, to become the latest corporation to roll out a multibillion-dollar bond offering, filing plans to sell a series of notes spanning in maturity from seven years to 40. Oracle plans to offer six separate tranches, including notes due in seven years, 10 years, 15 years, 20 years, 30 years and 40 years, according to a prospectus filed with the U.S. Securities and Exchange Commission.
Ensco plc (NYSE:ESV) in last trading activity advanced 9.56% to close at $27.28. Company weekly performance is 12.40% while its quarterly performance stands at 0.08%. Ensco plc (NYSE:ESV) is -48.98% away from its 52 week high. Ensco plc (NYSE:ESV) reported diluted first-quarter 2015 earnings of $1.49 a share (excluding one-time items) Revenues from floaters grew 7% to $695 million in first-quarter 2015 from $652 million a year ago. The growth was primarily backed by the return of ENSCO 5004, ENSCO 5005 and ENSCO 5006 to the operating fleet.
On last trading day Alimera Sciences, Inc. (NASDAQ:ALIM) moved down -5.63% to close at $4.36. Its volatility for the week is 8.98% while volatility for the month is 6.40%. ALIM’s EPS growth for past 5 years was 51.70%. Alimera Sciences, Inc. (NASDAQ:ALIM) monthly performance is -12.97%. Alimera Sciences, Inc. (MASDAQ:ALIM) announced on 22 April, that many retina specialists throughout the U.S. are now using Iluvien (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME).
Merck & Co. Inc. (NYSE:MRK) has 0.04% insider ownership while its institutional ownership stands at 75.70%. In last trading activity company’s stock closed at $59.56. On 28 April, Merck (NYSE:MRK) announced financial results for the first quarter of 2015. First-Quarter 2015 Worldwide Sales Were $9.4 Billion, a Decrease of 8 Percent, Reflecting Net Unfavorable Impact of Acquisitions and Divestitures and a 5 Percent Negative Impact from Foreign Exchange.
On last trading day Boulder Brands, Inc. (NASDAQ:BDBD) moved down -2.55% to close at $9.54. Its volatility for the week is 3.18% while volatility for the month is 3.11%. BDBD’s sales growth for past 5 years was 16.60% and its EPS growth for past 5 years was 26.42%. Boulder Brands, Inc. (NASDAQ:BDBD) monthly performance is 0.10%. Wedbush began coverage on shares of Boulder Brands Inc. (NASDAQ:SMBL) in a report issued on Tuesday. The firm issued a neutral rating on the stock.